Better Diabetes Control, quality - educate to achieve compliance. - MINERVA
Study identifier:NIS-CPO-XXX-2012/1
ClinicalTrials.gov identifier:NCT01728714
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Prospective study to evaluate impact of an educational programme about diabetes, comparing to normal clinical practice, on treatment compliance and disease control of people with type 2 diabetes followed in primary care units in Portugal
Medical condition
Diabetes Type 2
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
227
Study type
Observational
Age
18 Years +
Date
Study Start Date: 19 May 2014
Primary Completion Date: 05 Dec 2018
Study Completion Date: 05 Dec 2018
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Oct 2023 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Adults over 18 years old Adults over 18 years old, with type 2 diabetes, HbA1c <= 8,5%, treated with oral antidiabetics at least for 6 months submitted to an educational programme during 1 year | - |
| Adults with HbA1c <= 8,5% Adults over 18 years old, with type 2 diabetes, HbA1c <= 8,5%, treated with oral antidiabetics at least for 6 months followed according to normal clinical practice during 1 year | - |
Contacts
Investigators
Principal Investigator
Cláudia Antão
Research Site 01
